Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT05241769
Eligibility Criteria:
Inclusion Criteria:
* Patients of 18 years of age or higher
* Patients commenced on mepolizumab within the BRSAS network
* Patients who have at least 1 mepolizumab injection and with at least 3 months follow-up data from the time of treatment initiation
* Patients must be able and willing to give informed consent to participate in the study . An Interpreter will be provided for those patients where English is not their first language.
Exclusion Criteria:
* Refusal or inability to provide informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05241769
Study Brief:
Protocol Section:
NCT05241769